Recurrence
Welcome,         Profile    Billing    Logout  
 99 Companies   136 Products   136 Products   122 Mechanisms of Action   5 Trials   1111 News 


«12345678910111213...1617»
  • ||||||||||  tasadenoturev (DNX-2401) / DNAtrix
    Trial primary completion date, Oncolytic virus:  D24GBM: Virus DNX2401 and Temozolomide in Recurrent Glioblastoma (clinicaltrials.gov) -  Jun 11, 2015   
    P1,  N=31, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2014 Trial primary completion date: Mar 2015 --> Dec 2015
  • ||||||||||  verapamil intralesional / Stada
    Enrollment change, Trial termination, Trial primary completion date:  Verapamil vs Steroid to Prevent Keloid Recurrence (clinicaltrials.gov) -  Jun 11, 2015   
    P4,  N=14, Terminated, 
    Trial primary completion date: Sep 2014 --> Jul 2015 N=30 --> 14 | Recruiting --> Terminated | Trial primary completion date: Oct 2013 --> Mar 2014; Objective of study achieved after interim analysis.
  • ||||||||||  esmolol / Generic mfg.
    Enrollment closed, Trial primary completion date:  Postoperative Analgesia Impact of Narcotic Free Anesthesia (clinicaltrials.gov) -  May 29, 2015   
    P=N/A,  N=84, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Mar 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Jan 2013
  • ||||||||||  Trial completion:  Phone Interview to Prevent Recurring Opioid Overdoses (clinicaltrials.gov) -  May 28, 2015   
    P=N/A,  N=30, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2014 --> Jan 2013 Enrolling by invitation --> Completed
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  SCORE: Salvage Cryotherapy in Recurrent Prostate Cancer (clinicaltrials.gov) -  May 27, 2015   
    P=N/A,  N=60, Terminated, 
    Enrolling by invitation --> Completed N=800 --> 60 | Recruiting --> Terminated | Trial primary completion date: Jun 2014 --> Jun 2012; Study was ended due to low enrollment
  • ||||||||||  Enrollment open:  Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence (clinicaltrials.gov) -  May 27, 2015   
    P2/3,  N=200, Recruiting, 
    N=800 --> 60 | Recruiting --> Terminated | Trial primary completion date: Jun 2014 --> Jun 2012; Study was ended due to low enrollment Not yet recruiting --> Recruiting
  • ||||||||||  Enrollment open, Tumor cell:  Circulating Tumor Cells in Operative Blood (clinicaltrials.gov) -  May 21, 2015   
    P=N/A,  N=20, Recruiting, 
    Active, not recruiting --> Completed | N=10 --> 6 | Trial primary completion date: Dec 2014 --> May 2013 Not yet recruiting --> Recruiting
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Regional Anesthesia and Lung Cancer Recurrence (clinicaltrials.gov) -  May 19, 2015   
    P=N/A,  N=67, Terminated, 
    Recruiting --> Completed N=1532 --> 67 | Recruiting --> Terminated | Trial primary completion date: Aug 2013 --> Dec 2015; The principal investigator decided to close this study site.
  • ||||||||||  clofarabine / Generic mfg.
    Trial completion, Trial primary completion date:  Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia. (clinicaltrials.gov) -  May 19, 2015   
    P1,  N=36, Completed, 
    N=1532 --> 67 | Recruiting --> Terminated | Trial primary completion date: Aug 2013 --> Dec 2015; The principal investigator decided to close this study site. Suspended --> Completed | Trial primary completion date: Jan 2013 --> Dec 2014
  • ||||||||||  chloroquine phosphate / Generic mfg., primaquine / Generic mfg.
    Enrollment closed, Trial primary completion date:  Safety and Efficacy of Chloroquine and Primaquine for Vivax Malaria in Bhutan (clinicaltrials.gov) -  Apr 23, 2015   
    P=N/A,  N=50, Active, not recruiting, 
    No longer recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: May 2015 --> Sep 2015
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  BREAC-AUT: Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT (clinicaltrials.gov) -  Apr 21, 2015   
    P=N/A,  N=101, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed | N=150 --> 101 | Trial primary completion date: Dec 2013 --> Dec 2014
  • ||||||||||  NeuVax (nelipepimut-S) / Dr. Reddy's
    Enrollment closed, Trial primary completion date:  PRESENT: Efficacy and Safety Study of NeuVax (clinicaltrials.gov) -  Apr 15, 2015   
    P3,  N=700, Active, not recruiting, 
    Trial primary completion date: Nov 2015 --> Sep 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Apr 2018
  • ||||||||||  Trial primary completion date:  FACBC for Recurrent Prostate Cancer (clinicaltrials.gov) -  Apr 15, 2015   
    P2,  N=25, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Apr 2018 Trial primary completion date: Mar 2015 --> Sep 2015
  • ||||||||||  Cimzia (certolizumab pegol) / Astellas, UCB
    Trial primary completion date:  Cimzia Versus Mesalamine for Crohn's Recurrence (clinicaltrials.gov) -  Apr 15, 2015   
    P4,  N=24, Recruiting, 
    Trial primary completion date: Mar 2015 --> Sep 2015 Trial primary completion date: Dec 2014 --> Dec 2016
  • ||||||||||  Lodonal (naltrexone low dose oral) / Immune Therap, Statera BioPharma
    Enrollment closed:  Low-Dose Naltrexone for Depression Relapse and Recurrence (clinicaltrials.gov) -  Apr 8, 2015   
    P2,  N=36, Active, not recruiting, 
    Enrolling by invitation --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion:  MAPS Group Therapy Model for Bipolar Disorder (clinicaltrials.gov) -  Apr 8, 2015   
    P=N/A,  N=68, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed
  • ||||||||||  Trial completion:  Prevention of Recurrence in Depression With Drugs and CT (clinicaltrials.gov) -  Apr 2, 2015   
    P4,  N=452, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Jun 2016 Active, not recruiting --> Completed
  • ||||||||||  midazolam hydrochloride / Generic mfg.
    Trial completion, Trial primary completion date:  2-octyl Cyanoacrylate for Closure of Urethrocutaneous Fistula. (clinicaltrials.gov) -  Mar 24, 2015   
    P3,  N=42, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Apr 2016 --> Jan 2015
  • ||||||||||  sorafenib / Generic mfg.
    Enrollment change:  Sorafenib in Hormone Na (clinicaltrials.gov) -  Mar 7, 2015   
    P2,  N=0, Withdrawn, 
    N=44 --> 20 N=60 --> 0
  • ||||||||||  Enrollment closed:  RRR: Reducing Risk of Recurrence (clinicaltrials.gov) -  Mar 5, 2015   
    P=N/A,  N=150, Active, not recruiting, 
    N=60 --> 0 Recruiting --> Active, not recruiting